0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurorehabilitation Devices Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-11Y9276
Home | Market Reports
Global Neurorehabilitation Devices Market Size Status and Forecast 2022
BUY CHAPTERS

Global Neurorehabilitation Devices Market Research Report 2026

Code: QYRE-Auto-11Y9276
Report
2026-04-10
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurorehabilitation Devices Market Size

The global Neurorehabilitation Devices market was valued at US$ 1890 million in 2025 and is anticipated to reach US$ 4262 million by 2032, at a CAGR of 12.5% from 2026 to 2032.

Neurorehabilitation Devices Market

Neurorehabilitation Devices Market

Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumours, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics
This report delivers a comprehensive overview of the global Neurorehabilitation Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neurorehabilitation Devices. The Neurorehabilitation Devices market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neurorehabilitation Devices market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neurorehabilitation Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Neurorehabilitation Devices Market Report

Report Metric Details
Report Name Neurorehabilitation Devices Market
Accounted market size in 2025 US$ 1890 million
Forecasted market size in 2032 US$ 4262 million
CAGR 12.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Implantable Neurorehabilitation System
  • Neurorobotic System
  • Brain Computer Interface
  • Non-invasive Stimulators
  • Other
Segment by Application
  • Hospitals
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Yiruide, Magstim, VISHEE, Ekso Bionics, Alter G, MagVenture, Tyromotion, Soterix Medical, Neuroelectrics, Bionik Laboratories, Helius Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Neurorehabilitation Devices companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Neurorehabilitation Devices Market growing?

Ans: The Neurorehabilitation Devices Market witnessing a CAGR of 12.5% during the forecast period 2026-2032.

What is the Neurorehabilitation Devices Market size in 2032?

Ans: The Neurorehabilitation Devices Market size in 2032 will be US$ 4262 million.

What is the market share of major companies in Neurorehabilitation Devices Market?

Ans: Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%.

Who are the main players in the Neurorehabilitation Devices Market report?

Ans: The main players in the Neurorehabilitation Devices Market are Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Yiruide, Magstim, VISHEE, Ekso Bionics, Alter G, MagVenture, Tyromotion, Soterix Medical, Neuroelectrics, Bionik Laboratories, Helius Medical

What are the Application segmentation covered in the Neurorehabilitation Devices Market report?

Ans: The Applications covered in the Neurorehabilitation Devices Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Neurorehabilitation Devices Market report?

Ans: The Types covered in the Neurorehabilitation Devices Market report are Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurorehabilitation Devices Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Implantable Neurorehabilitation System
1.2.3 Neurorobotic System
1.2.4 Brain Computer Interface
1.2.5 Non-invasive Stimulators
1.2.6 Other
1.3 Market by Application
1.3.1 Global Neurorehabilitation Devices Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation Devices Market Perspective (2021–2032)
2.2 Global Neurorehabilitation Devices Growth Trends by Region
2.2.1 Global Neurorehabilitation Devices Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Neurorehabilitation Devices Historic Market Size by Region (2021–2026)
2.2.3 Neurorehabilitation Devices Forecasted Market Size by Region (2027–2032)
2.3 Neurorehabilitation Devices Market Dynamics
2.3.1 Neurorehabilitation Devices Industry Trends
2.3.2 Neurorehabilitation Devices Market Drivers
2.3.3 Neurorehabilitation Devices Market Challenges
2.3.4 Neurorehabilitation Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation Devices Players by Revenue
3.1.1 Global Top Neurorehabilitation Devices Players by Revenue (2021–2026)
3.1.2 Global Neurorehabilitation Devices Revenue Market Share by Players (2021–2026)
3.2 Global Top Neurorehabilitation Devices Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Neurorehabilitation Devices Revenue
3.4 Global Neurorehabilitation Devices Market Concentration Ratio
3.4.1 Global Neurorehabilitation Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Devices Revenue in 2025
3.5 Global Key Players of Neurorehabilitation Devices Head Offices and Areas Served
3.6 Global Key Players of Neurorehabilitation Devices, Products and Applications
3.7 Global Key Players of Neurorehabilitation Devices, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Neurorehabilitation Devices Breakdown Data by Type
4.1 Global Neurorehabilitation Devices Historic Market Size by Type (2021–2026)
4.2 Global Neurorehabilitation Devices Forecasted Market Size by Type (2027–2032)
5 Neurorehabilitation Devices Breakdown Data by Application
5.1 Global Neurorehabilitation Devices Historic Market Size by Application (2021–2026)
5.2 Global Neurorehabilitation Devices Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Neurorehabilitation Devices Market Size (2021–2032)
6.2 North America Neurorehabilitation Devices Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Neurorehabilitation Devices Market Size by Country (2021–2026)
6.4 North America Neurorehabilitation Devices Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurorehabilitation Devices Market Size (2021–2032)
7.2 Europe Neurorehabilitation Devices Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Neurorehabilitation Devices Market Size by Country (2021–2026)
7.4 Europe Neurorehabilitation Devices Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Devices Market Size (2021–2032)
8.2 Asia-Pacific Neurorehabilitation Devices Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2021–2026)
8.4 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neurorehabilitation Devices Market Size (2021–2032)
9.2 Latin America Neurorehabilitation Devices Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Neurorehabilitation Devices Market Size by Country (2021–2026)
9.4 Latin America Neurorehabilitation Devices Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Devices Market Size (2021–2032)
10.2 Middle East & Africa Neurorehabilitation Devices Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2021–2026)
10.4 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neurorehabilitation Devices Introduction
11.1.4 Medtronic Revenue in Neurorehabilitation Devices Business (2021–2026)
11.1.5 Medtronic Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Neurorehabilitation Devices Introduction
11.2.4 Abbott Laboratories Revenue in Neurorehabilitation Devices Business (2021–2026)
11.2.5 Abbott Laboratories Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Neurorehabilitation Devices Introduction
11.3.4 Boston Scientific Revenue in Neurorehabilitation Devices Business (2021–2026)
11.3.5 Boston Scientific Recent Development
11.4 Bioness
11.4.1 Bioness Company Details
11.4.2 Bioness Business Overview
11.4.3 Bioness Neurorehabilitation Devices Introduction
11.4.4 Bioness Revenue in Neurorehabilitation Devices Business (2021–2026)
11.4.5 Bioness Recent Development
11.5 Hocoma AG
11.5.1 Hocoma AG Company Details
11.5.2 Hocoma AG Business Overview
11.5.3 Hocoma AG Neurorehabilitation Devices Introduction
11.5.4 Hocoma AG Revenue in Neurorehabilitation Devices Business (2021–2026)
11.5.5 Hocoma AG Recent Development
11.6 Neuronetics
11.6.1 Neuronetics Company Details
11.6.2 Neuronetics Business Overview
11.6.3 Neuronetics Neurorehabilitation Devices Introduction
11.6.4 Neuronetics Revenue in Neurorehabilitation Devices Business (2021–2026)
11.6.5 Neuronetics Recent Development
11.7 Yiruide
11.7.1 Yiruide Company Details
11.7.2 Yiruide Business Overview
11.7.3 Yiruide Neurorehabilitation Devices Introduction
11.7.4 Yiruide Revenue in Neurorehabilitation Devices Business (2021–2026)
11.7.5 Yiruide Recent Development
11.8 Magstim
11.8.1 Magstim Company Details
11.8.2 Magstim Business Overview
11.8.3 Magstim Neurorehabilitation Devices Introduction
11.8.4 Magstim Revenue in Neurorehabilitation Devices Business (2021–2026)
11.8.5 Magstim Recent Development
11.9 VISHEE
11.9.1 VISHEE Company Details
11.9.2 VISHEE Business Overview
11.9.3 VISHEE Neurorehabilitation Devices Introduction
11.9.4 VISHEE Revenue in Neurorehabilitation Devices Business (2021–2026)
11.9.5 VISHEE Recent Development
11.10 Ekso Bionics
11.10.1 Ekso Bionics Company Details
11.10.2 Ekso Bionics Business Overview
11.10.3 Ekso Bionics Neurorehabilitation Devices Introduction
11.10.4 Ekso Bionics Revenue in Neurorehabilitation Devices Business (2021–2026)
11.10.5 Ekso Bionics Recent Development
11.11 Alter G
11.11.1 Alter G Company Details
11.11.2 Alter G Business Overview
11.11.3 Alter G Neurorehabilitation Devices Introduction
11.11.4 Alter G Revenue in Neurorehabilitation Devices Business (2021–2026)
11.11.5 Alter G Recent Development
11.12 MagVenture
11.12.1 MagVenture Company Details
11.12.2 MagVenture Business Overview
11.12.3 MagVenture Neurorehabilitation Devices Introduction
11.12.4 MagVenture Revenue in Neurorehabilitation Devices Business (2021–2026)
11.12.5 MagVenture Recent Development
11.13 Tyromotion
11.13.1 Tyromotion Company Details
11.13.2 Tyromotion Business Overview
11.13.3 Tyromotion Neurorehabilitation Devices Introduction
11.13.4 Tyromotion Revenue in Neurorehabilitation Devices Business (2021–2026)
11.13.5 Tyromotion Recent Development
11.14 Soterix Medical
11.14.1 Soterix Medical Company Details
11.14.2 Soterix Medical Business Overview
11.14.3 Soterix Medical Neurorehabilitation Devices Introduction
11.14.4 Soterix Medical Revenue in Neurorehabilitation Devices Business (2021–2026)
11.14.5 Soterix Medical Recent Development
11.15 Neuroelectrics
11.15.1 Neuroelectrics Company Details
11.15.2 Neuroelectrics Business Overview
11.15.3 Neuroelectrics Neurorehabilitation Devices Introduction
11.15.4 Neuroelectrics Revenue in Neurorehabilitation Devices Business (2021–2026)
11.15.5 Neuroelectrics Recent Development
11.16 Bionik Laboratories
11.16.1 Bionik Laboratories Company Details
11.16.2 Bionik Laboratories Business Overview
11.16.3 Bionik Laboratories Neurorehabilitation Devices Introduction
11.16.4 Bionik Laboratories Revenue in Neurorehabilitation Devices Business (2021–2026)
11.16.5 Bionik Laboratories Recent Development
11.17 Helius Medical
11.17.1 Helius Medical Company Details
11.17.2 Helius Medical Business Overview
11.17.3 Helius Medical Neurorehabilitation Devices Introduction
11.17.4 Helius Medical Revenue in Neurorehabilitation Devices Business (2021–2026)
11.17.5 Helius Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Neurorehabilitation Devices Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Implantable Neurorehabilitation System
 Table 3. Key Players of Neurorobotic System
 Table 4. Key Players of Brain Computer Interface
 Table 5. Key Players of Non-invasive Stimulators
 Table 6. Key Players of Other
 Table 7. Global Neurorehabilitation Devices Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Neurorehabilitation Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Neurorehabilitation Devices Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Neurorehabilitation Devices Market Share by Region (2021–2026)
 Table 11. Global Neurorehabilitation Devices Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Neurorehabilitation Devices Market Share by Region (2027–2032)
 Table 13. Neurorehabilitation Devices Market Trends
 Table 14. Neurorehabilitation Devices Market Drivers
 Table 15. Neurorehabilitation Devices Market Challenges
 Table 16. Neurorehabilitation Devices Market Restraints
 Table 17. Global Neurorehabilitation Devices Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Neurorehabilitation Devices Market Share by Players (2021–2026)
 Table 19. Global Top Neurorehabilitation Devices Players by Tier (Tier 1, Tier 2, and Tier 3), based on Neurorehabilitation Devices Revenue, 2025
 Table 20. Ranking of Global Top Neurorehabilitation Devices Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Neurorehabilitation Devices Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Neurorehabilitation Devices, Headquarters and Area Served
 Table 23. Global Key Players of Neurorehabilitation Devices, Products and Applications
 Table 24. Global Key Players of Neurorehabilitation Devices, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Neurorehabilitation Devices Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Neurorehabilitation Devices Revenue Market Share by Type (2021–2026)
 Table 28. Global Neurorehabilitation Devices Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Neurorehabilitation Devices Revenue Market Share by Type (2027–2032)
 Table 30. Global Neurorehabilitation Devices Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Neurorehabilitation Devices Revenue Market Share by Application (2021–2026)
 Table 32. Global Neurorehabilitation Devices Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Neurorehabilitation Devices Revenue Market Share by Application (2027–2032)
 Table 34. North America Neurorehabilitation Devices Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Neurorehabilitation Devices Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Neurorehabilitation Devices Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Neurorehabilitation Devices Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Neurorehabilitation Devices Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Neurorehabilitation Devices Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Neurorehabilitation Devices Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Neurorehabilitation Devices Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Neurorehabilitation Devices Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Neurorehabilitation Devices Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Neurorehabilitation Devices Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Neurorehabilitation Devices Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Neurorehabilitation Devices Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Neurorehabilitation Devices Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Neurorehabilitation Devices Market Size by Country (US$ Million), 2027–2032
 Table 49. Medtronic Company Details
 Table 50. Medtronic Business Overview
 Table 51. Medtronic Neurorehabilitation Devices Product
 Table 52. Medtronic Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 53. Medtronic Recent Development
 Table 54. Abbott Laboratories Company Details
 Table 55. Abbott Laboratories Business Overview
 Table 56. Abbott Laboratories Neurorehabilitation Devices Product
 Table 57. Abbott Laboratories Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 58. Abbott Laboratories Recent Development
 Table 59. Boston Scientific Company Details
 Table 60. Boston Scientific Business Overview
 Table 61. Boston Scientific Neurorehabilitation Devices Product
 Table 62. Boston Scientific Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 63. Boston Scientific Recent Development
 Table 64. Bioness Company Details
 Table 65. Bioness Business Overview
 Table 66. Bioness Neurorehabilitation Devices Product
 Table 67. Bioness Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 68. Bioness Recent Development
 Table 69. Hocoma AG Company Details
 Table 70. Hocoma AG Business Overview
 Table 71. Hocoma AG Neurorehabilitation Devices Product
 Table 72. Hocoma AG Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 73. Hocoma AG Recent Development
 Table 74. Neuronetics Company Details
 Table 75. Neuronetics Business Overview
 Table 76. Neuronetics Neurorehabilitation Devices Product
 Table 77. Neuronetics Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 78. Neuronetics Recent Development
 Table 79. Yiruide Company Details
 Table 80. Yiruide Business Overview
 Table 81. Yiruide Neurorehabilitation Devices Product
 Table 82. Yiruide Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 83. Yiruide Recent Development
 Table 84. Magstim Company Details
 Table 85. Magstim Business Overview
 Table 86. Magstim Neurorehabilitation Devices Product
 Table 87. Magstim Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 88. Magstim Recent Development
 Table 89. VISHEE Company Details
 Table 90. VISHEE Business Overview
 Table 91. VISHEE Neurorehabilitation Devices Product
 Table 92. VISHEE Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 93. VISHEE Recent Development
 Table 94. Ekso Bionics Company Details
 Table 95. Ekso Bionics Business Overview
 Table 96. Ekso Bionics Neurorehabilitation Devices Product
 Table 97. Ekso Bionics Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 98. Ekso Bionics Recent Development
 Table 99. Alter G Company Details
 Table 100. Alter G Business Overview
 Table 101. Alter G Neurorehabilitation Devices Product
 Table 102. Alter G Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 103. Alter G Recent Development
 Table 104. MagVenture Company Details
 Table 105. MagVenture Business Overview
 Table 106. MagVenture Neurorehabilitation Devices Product
 Table 107. MagVenture Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 108. MagVenture Recent Development
 Table 109. Tyromotion Company Details
 Table 110. Tyromotion Business Overview
 Table 111. Tyromotion Neurorehabilitation Devices Product
 Table 112. Tyromotion Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 113. Tyromotion Recent Development
 Table 114. Soterix Medical Company Details
 Table 115. Soterix Medical Business Overview
 Table 116. Soterix Medical Neurorehabilitation Devices Product
 Table 117. Soterix Medical Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 118. Soterix Medical Recent Development
 Table 119. Neuroelectrics Company Details
 Table 120. Neuroelectrics Business Overview
 Table 121. Neuroelectrics Neurorehabilitation Devices Product
 Table 122. Neuroelectrics Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 123. Neuroelectrics Recent Development
 Table 124. Bionik Laboratories Company Details
 Table 125. Bionik Laboratories Business Overview
 Table 126. Bionik Laboratories Neurorehabilitation Devices Product
 Table 127. Bionik Laboratories Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 128. Bionik Laboratories Recent Development
 Table 129. Helius Medical Company Details
 Table 130. Helius Medical Business Overview
 Table 131. Helius Medical Neurorehabilitation Devices Product
 Table 132. Helius Medical Revenue in Neurorehabilitation Devices Business (US$ Million), 2021–2026
 Table 133. Helius Medical Recent Development
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources
 Table 137. Authors List of This Report


List of Figures
 Figure 1. Neurorehabilitation Devices Picture
 Figure 2. Global Neurorehabilitation Devices Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Neurorehabilitation Devices Market Share by Type: 2025 vs 2032
 Figure 4. Implantable Neurorehabilitation System Features
 Figure 5. Neurorobotic System Features
 Figure 6. Brain Computer Interface Features
 Figure 7. Non-invasive Stimulators Features
 Figure 8. Other Features
 Figure 9. Global Neurorehabilitation Devices Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Neurorehabilitation Devices Market Share by Application: 2025 vs 2032
 Figure 11. Hospitals Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Other Case Studies
 Figure 14. Neurorehabilitation Devices Report Years Considered
 Figure 15. Global Neurorehabilitation Devices Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Neurorehabilitation Devices Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Neurorehabilitation Devices Market Share by Region: 2025 vs 2032
 Figure 18. Global Neurorehabilitation Devices Market Share by Players in 2025
 Figure 19. Global Neurorehabilitation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Neurorehabilitation Devices Revenue in 2025
 Figure 21. North America Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Neurorehabilitation Devices Market Share by Country (2021–2032)
 Figure 23. United States Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Neurorehabilitation Devices Market Share by Country (2021–2032)
 Figure 27. Germany Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Neurorehabilitation Devices Market Share by Region (2021–2032)
 Figure 35. China Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Neurorehabilitation Devices Market Share by Country (2021–2032)
 Figure 43. Mexico Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Neurorehabilitation Devices Market Share by Country (2021–2032)
 Figure 47. Israel Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Neurorehabilitation Devices Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Medtronic Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 51. Abbott Laboratories Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 52. Boston Scientific Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 53. Bioness Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 54. Hocoma AG Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 55. Neuronetics Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 56. Yiruide Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 57. Magstim Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 58. VISHEE Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 59. Ekso Bionics Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 60. Alter G Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 61. MagVenture Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 62. Tyromotion Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 63. Soterix Medical Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 64. Neuroelectrics Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 65. Bionik Laboratories Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 66. Helius Medical Revenue Growth Rate in Neurorehabilitation Devices Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI